Madras Fertilizers Ltd. - Research Center
590134 MADRASFERT Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 21 | Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | |
|---|---|---|---|---|---|
| Sales | 877.02 | 630.06 | 988.85 | 350.51 | 614.77 |
| Operating profit | 66.26 | 26.99 | 119.77 | -86.01 | -44.09 |
| Interest | 39.46 | 45.01 | 50.38 | 39.91 | 51.00 |
| Gross profit | 29.68 | -15.59 | 79.49 | -123.02 | -88.71 |
| EPS (Rs) | 0.83 | -1.84 | 3.98 | -8.32 | -6.19 |
Half yearly
results in details
| Sep ' 21 | Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | |
|---|---|---|---|---|---|
| Other income | 2.88 | 2.43 | 10.10 | 2.90 | 6.38 |
| Stock adjustment | -9.99 | -3.24 | -44.92 | -33.68 | 19.89 |
| Raw material | 565.66 | 483.99 | 800.14 | 352.29 | 527.84 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 49.24 | 48.36 | 48.56 | 47.41 | 47.39 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 205.85 | 73.96 | 65.30 | 70.50 | 63.74 |
| Provisions made | - | - | - | - | - |
| Depreciation | 16.26 | 14.04 | 15.38 | 11.00 | 11.00 |
| Taxation | - | - | - | - | - |
| Net profit / loss | 13.42 | -29.63 | 64.11 | -134.02 | -99.71 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 161.10 | 161.10 | 161.10 | 161.10 | 161.10 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 7.56 | 4.28 | 12.11 | -24.54 | -7.17 |
| GPM (%) | 3.37 | -2.46 | 7.96 | -34.81 | -14.28 |
| NPM (%) | 1.53 | -4.68 | 6.42 | -37.92 | -16.05 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis